Anhui Huaheng Biotechnology Co., Ltd. Stock: price and insider trades · China
华恒生物
Anhui Huaheng Biotechnology Co., Ltd.: what insiders have been doing
Anhui Huaheng Biotechnology Co., Ltd. is a Health Care company. Its directors and officers file their transactions with SSE / SZSE (CSRC). The last twelve months, up to 5 November 2026, brought 1 filing signed by 1 insider.
Only sales appear on the open market, 1 sale in all totalling €72k, filed by 1 insider. 唐思青 filed the largest sale, €72k, on 22 September 2026.
Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
For context, the typical company on the same exchange (median of 514 companies) published 2 filings over the same period, against 1 filing here. Since 2025, the database holds no purchases and 2 sales by insiders of the company.
In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleAnalyst consensus: bullish or bearish?
Analysts rate Anhui Huaheng Biotechnology Co., Ltd. Strong Buy (bullish), based on 3 analysts. Average price target: CN¥36.03.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
About Anhui Huaheng Biotechnology Co., Ltd.
华恒生物 is a company in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and production of biological and pharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
